{"id":32355,"date":"2020-07-16T14:49:13","date_gmt":"2020-07-16T13:49:13","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=32355"},"modified":"2021-11-21T12:39:31","modified_gmt":"2021-11-21T12:39:31","slug":"gut-brain-axis-2021","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2021\/","title":{"rendered":"Gut-Brain Axis 2021"},"content":{"rendered":"
\n

\n\tDescription\n\t<\/h2>\n

The Gut-Brain Axis event, brings together leading scientists, physicians, and senior leaders to explore the potential insights into the Microbiota-Gut-Brain Axis, the Human Microbiome Market that exhibits significant potential in the near future.<\/p>\n

The ability of gut microbiota to communicate with the brain is emerging as an exciting concept in health and disease. Mounting evidence, mostly from rodent studies, suggests that gut microbes help shape normal neural development, brain biochemistry, and behaviour.<\/p>\n

The Gut-Brain Axis will be dedicated to help large pharma, biotech, academics and clinicians exploring and understand the Human Microbiome Market, GBA in demonstrating disease causation. Over the last decade, the microbiome has become one of the trendiest areas of biology, and the research has made clear that the microbiome is fundamental to overall health.<\/p>\n

\n\tKey Practical Points\n\t<\/h2>\n\t